Join Dr. Sicard for an examination of the systemic effects of myocardial infarction using high-frequency ultrasound and photoacoustics.
In this webinar, Pierre Sicard, PhD, a Research Engineer at INSERM in Montpellier, France, presented how real-time measures of vascular hypoxia are detected in the heart, brain and peripheral organs post-infarct. He shared cutting-edge multi-modal anatomical, physiological, and oxygenation data from his extensive work in the field.
Key Topics Include:
- Photoacoustic Imaging (PAI) is able to detect and track hypoxia in the LV anterior wall after myocardial infarction
- Experimental myocardial infarction induced an early and transient decrease of sO2 in the brain, kidney, and liver
- sO2 level in vital organs was significantly correlated with LV dysfunction and circulating biomarkers (creatinine, ASAT, and ALAT)
- Non-invasive PAI enabled a robust and time-dependent sO2 mapping in peripheral organs and the brain after MI
Who Should Attend?
Researchers at any level who study myocardial infarction or ischemia anywhere in the body, those interested in photoacoustics or anyone interested in the use of ultrasound for imaging rodent models.
Click to watch the webinar recording. To view the presentation full screen simply click the square icon located in the bottom-right corner of the video-viewer.
Presenters
Research Engineer
Montpellier University
Dr. Pierre Sicard is a research engineer at INSERM in Montpellier, France. He leads the ultrasound/photoacoustic platform in Montpellier (IPAM/INSERM/ Montpellier University). Dr. Sicard obtained in 2007, from the University of Burgundy, a PhD in Cardiovascular physiology. He studied the interplay between oxidative stress, hypertension and their consequences on the heart. In 2007, he joined the cardiovascular division at St Thomas’ Hospital (King’s College London, UK) as a postdoctoral fellow to investigate the importance of p38 MAPK isoforms during experimental myocardial infarction. He continued his research in the Institute of Metabolic and Cardiovascular Diseases in Toulouse (France) in order to develop a bench to bedside project about the potential contribution of Gadd45 proteins in post-myocardial infarction remodeling. His current research interests focused on the mechanism involved in multiple-organ dysfunction after right or left ventricular myocardial infarction.
Webinar Host
FUJIFILM VisualSonics Inc.
FUJIFILM VisualSonics designs and manufactures ultra high frequency in vivo imaging systems, for both research and clinical use.
Additional Content From FUJIFILM VisualSonics Inc.
Combining Ultra High Frequency Ultrasound and Photoacoustic Imaging: A Significant Breakthrough in Oncology
Join Professor Annarosa Arcangeli as she discusses the use of multi-modal imaging to detect and monitor pancreatic and liver tumors.
Evaluation and Optimization of Right Ventricular and Lung Imaging Using High Frequency Ultrasound
Allison Rodgers discusses the value of imaging the mouse right ventricle and lungs using high-frequency ultrasound for models of cardiopulmonary physiology and associated diseases.
Related Content
Cardiovascular Autonomic Dysfunction in the Post-COVID Landscape: Detection and Management
Artur Fedorowski, MD, PhD, describes cardiovascular dysautonomia in COVID-19 and the diagnostics behind detecting Long COVID or Post-acute Sequalae of COVID-19.
Noninvasive Blood Pressure Monitoring Using Kent Scientific’s CODA® Systems
This virtual demo shows the basic setup and operation of Kent Scientific’s CODA® noninvasive blood pressure system.
APS Physiology in Disease Modeling and Drug Development Roundtable
Key opinion leaders in cardiovascular physiology and bioengineering discuss best practices and challenges when modeling cardiomyopathies and other cardiovascular diseases using stem cells, engineered tissues and other novel platforms.